Industry
Medical - Healthcare Information Services
BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.
Loading...
Open
2.25
Mkt cap
20M
Volume
122K
High
2.39
P/E Ratio
-2.71
52-wk high
8.35
Low
2.05
Div yield
N/A
52-wk low
1.43
Portfolio Pulse from Benzinga Insights
May 03, 2024 | 12:06 pm
Portfolio Pulse from Benzinga Insights
April 25, 2024 | 8:32 pm
Portfolio Pulse from Benzinga Newsdesk
March 08, 2024 | 5:34 pm
Portfolio Pulse from Benzinga Newsdesk
February 29, 2024 | 3:00 pm
Portfolio Pulse from Avi Kapoor
February 01, 2024 | 6:17 pm
Portfolio Pulse from Benzinga Newsdesk
February 01, 2024 | 5:35 pm
Portfolio Pulse from Benzinga Insights
February 01, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Newsdesk
February 01, 2024 | 2:01 pm
Portfolio Pulse from Benzinga Insights
February 01, 2024 | 1:06 pm
Portfolio Pulse from Avi Kapoor
February 01, 2024 | 12:51 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.